Education
About Us
Working with TipRanks
Follow Us
ReposiTrak (TRAK)
NYSE:TRAK
Earnings Data
Report Date
Sep 24, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
0.09Last Year’s EPS
0.08Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 15, 2025
|% Change Since: -2.18%
|Next Earnings Date:Sep 24, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue and net income growth, successful cross-selling, and a strong cash position. However, increased operating expenses and the FDA's extension of the compliance enforcement deadline were noted as challenges. Despite these challenges, the company remains optimistic about its growth prospects.Company Guidance
During ReposiTrak's fiscal third quarter 2025 earnings call, John Merrill, the CFO, provided guidance on the company's financial performance and strategic direction. The company reported a 16% growth in revenue to $5.9 million, with a significant increase in deferred revenue, indicating future growth. Net income grew by 27%, and the company aims to achieve 10-20% annual revenue growth. Their strategy focuses on expanding traceability and cross-selling their services, leading to increased profitability. Operating expenses increased by 7%, but the company maintains a strong cash position with $28.1 million on hand. ReposiTrak plans to continue returning 50% of its cash from operations to shareholders through dividends and stock buybacks, having already returned $25 million in capital. The company remains debt-free and is investing in growth through automation and customer onboarding.Revenue Growth
Revenue grew 16% in the third fiscal quarter to $5.9 million. Recurring revenue increased 15% to $5.8 million.
Net Income Growth
Net income grew 27% from $1.6 million to $2 million. GAAP net income to shareholders increased 33% from $1.4 million to $1.9 million.
Deferred Revenue Increase
Deferred revenue increased 70% to $4.2 million, indicating future revenue potential.
Cross-Selling Success
Cross-selling initiatives are gaining momentum, contributing to overall growth across all business lines.
Cash Position
Cash balance is over $28 million as of March 31, 2025, with significant cash generation and plans to return capital to shareholders.
---
TRAK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TRAK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 15, 2025 | $22.91 | $22.41 | -2.18% |
Feb 12, 2025 | $20.98 | $22.38 | +6.67% |
Nov 14, 2024 | $20.82 | $21.57 | +3.60% |
Sep 30, 2024 | $18.44 | $17.80 | -3.47% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does ReposiTrak (TRAK) report earnings?
ReposiTrak (TRAK) is schdueled to report earning on Sep 24, 2025, TBA Not Confirmed.
What is ReposiTrak (TRAK) earnings time?
ReposiTrak (TRAK) earnings time is at Sep 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TRAK EPS forecast?
TRAK EPS forecast for the fiscal quarter 2025 (Q4) is 0.09.
---